omniture

匯邦集團控股有限公司(納斯達克:AGBA)宣布2023年第一季度業(yè)績 中國內地及香港經(jīng)濟反彈提供巨大增長機會

2023-05-15 21:10 7068

2023年第一季度收入為1,110萬美元,較2022年同期大幅增長533%

香港2023年5月15日 /美通社/ -- 納斯達克上市、香港領先的一站式金融超市匯邦集團控股有限公司(AGBA),欣然宣布2023年第一季度的財務業(yè)績,期內收入為1,110萬美元,較2022年同比大幅增長逾5倍。 

2023年3月期間,AGBA集團錄得過去三年內最多的新業(yè)務申請。 AGBA預期今年剩余季度集團將繼續(xù)保持強勁增長。 AGBA集團對香港的經(jīng)濟反彈感到樂觀,認為反彈有賴邊境重新開放、內地游客的回歸以及疫情后強勁的國內需求。

2023年第一季度, AGBA 集團繼續(xù)進行科技部署,在客戶平臺(client portal)和顧問工具方面持續(xù)提升客戶體驗。 在平臺業(yè)務方面,AGBA集團引入10個新保險合作伙伴,新增170種以上新保險和投資產品至現(xiàn)時總共超過2千款金融產品;在分銷業(yè)務方面,AGBA集團與三個新分銷合作伙伴,以及一家大型本地銀行簽訂合作協(xié)議使用One Platform環(huán)一平臺服務。 同時,集團還啟動了一個新的孵化分銷渠道,與較小型的顧問團隊合作。 

2023年4月,AGBA集團與新加坡的Sony Life Financial Advisors達成收購協(xié)議,繼續(xù)推動AGBA集團的環(huán)球擴張計劃,該公司為新加坡一家持牌金融顧問和保險經(jīng)紀公司。 這一收購為AGBA集團在大灣區(qū)以外,擴展至東南亞的重要里程碑。

同樣在2023年4月,AGBA集團宣布了一項回購計劃,最多回購100萬股(最高價值1,000萬美元)。 回購反映AGBA集團致力回饋股東,為股東帶來價值,同時保持財務靈活性,以投資高增長機會。

匯邦集團控股有限公司集團總裁吳榮輝表示香港經(jīng)濟反彈和內地游客的回歸,加上我們持續(xù)對創(chuàng)新和擴張的承諾,為AGBA集團帶來一個充滿成長和繁榮的精彩季度。 我們將繼續(xù)致力于投資我們的業(yè)務,創(chuàng)造創(chuàng)新的技術并擴大我們的產品范圍,以保持領先地位并把握香港獨特的機遇。 2023 年對AGBA 的所有人來說將是令人興奮無比的一年。 

有關AGBA集團 2023 年第一季度財務業(yè)績和未來展望的詳細分析,請參閱集團網(wǎng)站 www.agba.com/ir。 

Safe Harbor Statement

This press release contains forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements that are other than statements of historical facts. When the Company uses words such as "may," "will," "intend," "should," "believe," "expect," "anticipate," "project," "estimate" or similar expressions that do not relate solely to historical matters, it is making forward-looking statements. Forward-looking statements are not guarantees of future performance and involve risks and uncertainties that may cause the actual results to differ materially from the Company's expectations discussed in the forward-looking statements. These statements are subject to uncertainties and risks including, but not limited to, the following: the Company's goals and strategies; the Company's future business development; product and service demand and acceptance; changes in technology; economic conditions; the outcome of any legal proceedings that may be instituted against us following the consummation of the business combination; expectations regarding our strategies and future financial performance, including its future business plans or objectives, prospective performance and opportunities and competitors, revenues, products, pricing, operating expenses, market trends, liquidity, cash flows and uses of cash, capital expenditures, and our ability to invest in growth initiatives and pursue acquisition opportunities; reputation and brand; the impact of competition and pricing; government regulations; fluctuations in general economic and business conditions in Hong Kong and the international markets the Company plans to serve and assumptions underlying or related to any of the foregoing and other risks contained in reports filed by the Company with the SEC, the length and severity of the recent coronavirus outbreak, including its impacts across our business and operations. For these reasons, among others, investors are cautioned not to place undue reliance upon any forward-looking statements in this press release. Additional factors are discussed in the Company's filings with the SEC, which are available for review at www.sec.gov. The Company undertakes no obligation to publicly revise these forward–looking statements to reflect events or circumstances that arise after the date hereof.

關于AGBA集團

AGBA集團(納斯達克:"AGBA")成立于1993年,是一家以香港為基地的領先一站式金融超市,在粵港澳大灣區(qū)提供最廣泛的金融和醫(yī)療保健服務,通過以技術為主導的生態(tài)系統(tǒng),讓客戶能夠選擇最適合他們需求的方案。AGBA擁有四大業(yè)務:平臺業(yè)務、分銷業(yè)務、醫(yī)療保健業(yè)務和金融科技業(yè)務,均領先市場,深受超過400,000名個人和企業(yè)客戶的信賴。

如欲了解AGBA更多資料,請瀏覽AGBA網(wǎng)站: http://www.agba.com 

社交媒體:
agbagroup
LinkedIn | Twitter | Instagram | Facebook | YouTube

消息來源:AGBA Group Holding Limited
相關股票:
NASDAQ:AGBA
China-PRNewsire-300-300.png
醫(yī)藥健聞
微信公眾號“醫(yī)藥健聞”發(fā)布全球制藥、醫(yī)療、大健康企業(yè)最新的經(jīng)營動態(tài)。掃描二維碼,立即訂閱!
collection